IRVINE, CA--(Marketwired - Nov 5, 2014) - Masimo (NASDAQ: MASI) announced today that a new clinical study published in the Journal of the American College of Surgeons showed that noninvasive ...

June 30, 2010 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a handheld device (Pronto-7; Masimo) for noninvasive hemoglobin spot-check testing, along with saturation of ...

For spot-check SpHb measurement, Masimo Pronto ® is available in addition to Rad-67. Next Generation SpHb, available on these devices outside the U.S., significantly advances noninvasive hemoglobin ...

Hailed as a “potential game-changing technology,” Dr. Andrew J. Schuman—adjunct assistant professor of pediatrics at Dartmouth Medical School, contributing editor for Contemporary Pediatrics, and a ...

Noting that invasive blood hemoglobin measurement, while an important step in the management of blood loss, has drawbacks such as “consumption of valuable time, phlebotomy-induced anemia, pain, ...

Masimo (NASDAQ: MASI) today announced CE Mark clearance for the international release of the Masimo Pronto-7®-a palm-sized handheld device designed for quick and easy noninvasive spot-checking of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A hemoglobin electrophoresis test is a blood test used to measure and identify the different types of hemoglobin in your bloodstream. Hemoglobin is the protein inside red blood cells responsible for ...

Masimo (NASDAQ: MASI) announced today that a new consensus statement on postoperative anemia management was published in Anaesthesia by an international panel of clinicians specializing in patient ...